250-RICR-120-05-26. Air Pollution Control Regulation No. 26- Control of Organic Solvent Emissions from Manufacturers of Synthesized Pharmaceutical Products (version Periodic Refile, 12/31/2001 to 07/19/2007)

Effective 19 November 1992 Last Amended 8 April 1996 AIR POLLUTION CONTROL REGULATION NO. 26 CONTROL OF ORGANIC SOLVENT EMISSIONS FROM MANUFACTURE OF SYNTHESIZED PHARMACEUTICAL PRODUCTS RHODE ISLAND DEPARTMENT OF ENVIRONMENTAL MANAGEMENT DIVISION OF AIR RESOURCES AIR POLLUTION CONTROL REGULATION NO. 26 CONTROL OF ORGANIC SOLVENT EMISSIONS FROM MANUFACTURE OF SYNTHESIZED PHARMACEUTICAL PRODUCTS 26. Control of Organic Solvent Emissions from Manufacture of Synthesized Pharmaceutical Products 26.1 Definitions As used in these regulations, the following terms shall, where the context permits, be construed as follows: 26.1.1 "Condenser" means any device which cools a gas stream to a temperature which removes specific VOC by condensation. 26.1.2 "Control System" means any number of control devices, including condensers, which are designed and operated to reduce the quantity of VOC emitted to the atmosphere. 26.1.3 "Enclose" means to cover a volatile organic liquid surface in a manner such that it is not exposed to the atmosphere. 26.1.4 "Enforceable Document" is a construction permit or operating permit meeting the requirements of Air Pollution Control Regulation Number 9, an approval issued under this regulation, or a consent agreement. 26.1.5 "Facility" means all pollutant-emitting activities located in a building or buildings on one or more adjacent properties owned or operated by the same person. 26.1.6 "Halogenated Organic Compound" and "HOC" means the following compounds: (a) CFC-11 (trichlorofluoromethane) (b) CFC-12 (dichlorodifluoromethane) (c) CFC-113 (1,1,1-trichloro 2,2,2-trifluoroethane) (d) CFC-114 (1,2-dichloro 1,1,2,2-tetrafluoroethane) (e) CFC-115 (chloropentafluoroethane) (f) HCFC-22 (chlorodifluoromethane) (g) HCFC-123 (1,1,1-trifluoro 2,2-dichloroethane) (h) HCFC-124 (2-chloro 1,1,1,2-tetrafluoroethane) (i) HCFC-141b (1,1-dichloro 1-fluoroethane) (j) HCFC-142b (1-chloro 1,1-difluoroethane) (k) methyl chloroform (1,1,1-trichloroethane) (l) methylene chloride (dichloromethane) 26.1.7 "Person" means an individual, trust, firm, joint stock company, corporation (including a quasi-governmental corporation), partnership, association, syndicate, municipality, municipal or state agency, fire district, club, non-profit agency or any subdivision, commission, department, bureau, agency or department of state or federal government (including quasi-governmental corporation) or of any interstate body. 26.1.8 "Pharmaceutical Product and Intermediate" means any drug or chemical substance or any intermediate used to make a drug or chemical substance which is intended to be administered to a person or animal to prevent or cure disease or otherwise enhance physical or mental welfare. 26.1.9 "Potential Emissions" means the maximum capacity of a stationary source to emit a pollutant under its physical or operational design unless limited by the conditions of a federally enforceable document. 26.1.10 "Production equipment exhaust system" means a device for collecting and directing out of the work area VOC fugitive emissions from reactor openings, centrifuge openings, and other vessel openings for the purpose of protecting workers from excessive VOC exposure. 26.1.11 "Reactor" means a vat or vessel, which may be jacketed to permit temperature control, designed to contain chemical reactions. 26.1.12 "Separation operation" means a physical or chemical process that separates a mixture of compounds and solvents into two or more components. Specific mechanisms include but are not limited to: extraction, centrifugation, filtration, and crystallization. 26.1.13 "Synthesized pharmaceutical manufacturing" means manufacture of pharmaceutical products and intermediates by chemical synthesis. The production and recovery of materials produced via fermentation, extraction of organic chemicals from vegetative materials or animal tissues, and formulation and packaging of the product are not considered synthesized pharmaceutical manufacturing. 26.1.14 "Volatile organic compound" and "VOC" means any organic compound which participates in atmospheric photochemical reactions. This includes any of the organic compounds other than the following compounds: (a) acetone (b) CFC-11 (trichlorofluoromethane) (c) CFC-12 (dichlorodifluoromethane) (d) CFC-113 (1,1,1-trichloro 2,2,2-trifluoroethane) (e) CFC-114 (1,2-dichloro 1,1,2,2-tetrafluoroethane) (f) CFC-115 (chloropentafluoroethane) (g) ethane (h) HCFC-22 (chlorodifluoromethane) (i) HCFC-123 (1,1,1-trifluoro 2,2-dichloroethane) (j) HCFC-124 (2-chloro 1,1,1,2-tetrafluoroethane) (k) HCFC-141b (1,1-dichloro 1-fluoroethane) (l) HCFC-142b (1-chloro 1,1-difluoroethane) (m) HFC-23 (trifluoromethane) (n) HFC-125 (pentafluoroethane) (o) HFC-134 (1,1,2,2-tetrafluoroethane) (p) HFC-134a (1,1,1,2-tetrafluoroethane) (q) HFC-143a (1,1,1-trifluoroethane) (r) HFC-152a (1,1-difluoroethane) (s) methane (t) methyl chloroform (1,1,1-trichloroethane) (u) methylene chloride (dichloromethane) (v) parachlorobenzotrifluoride (PCBTF) (w) cyclic, branched, or linear completely methylated siloxanes (x) The perfluorocarbon compounds which fall into these classes: (1) Cyclic, branched, or linear, completely fluorinated alkanes; (2) Cyclic, branched, or linear, completely fluorinated ethers with no unsaturations; (3) Cyclic, branched, or linear, completely fluorinated tertiary amines with no unsaturations; and (4) Sulfur containing perfluorocarbons with no unsaturations and with sulfur bonds only to carbon and fluorine. These compounds have been determined to have negligible photochemical reactivity. For purposes of determining compliance with emission limits, VOC will be measured by the approved test methods. Where such a method also inadvertently measures compounds with negligible photochemical reactivity, as defined above, an owner or operator may exclude these negligible photochemical reactive compounds when determining compliance with an emissions standard. Exempt solvents will be treated as water in "pounds of VOC per gallon of coating minus water" calculations. 26.2 Applicability 26.2.1 This regulation applies to the following sources of volatile organic compounds (VOC) at all synthesized pharmaceutical manufacturing facilities: (a) Reactors; (b) Distillation operations; (c) Crystallizers; (d) Centrifuges; (e) Vacuum dryers; (f) Air dryers; (g) Production equipment exhaust systems; (h) Rotary vacuum filters and other filters; (i) Storage tanks; (j) In-process tanks; and (k) Leaks. 26.2.2 The owner or operator of a synthesized pharmaceutical manufacturing facility subject to this regulation shall control the VOC emissions from each vent which has the potential to emit 15 pounds per day [lb/day] (6.8 kilograms per day (kg/day)) or more of VOC from reactors, distillation operations, crystallizers, centrifuges, and vacuum dryers. VOC emissions shall be controlled in accordance with the requirements in Section 26.3. 26.2.3 Where ever the term "Volatile Organic Compound" or "VOC" is used in Sections 26.2 through 26.7, this term should be read as "Volatile Organic Compound and Halogenated Organic Compound" or "VOC and HOC". 26.2.4 An owner or operator of a facility which has sources whose emissions are below the applicability threshold in Subsection 26.2.2 shall comply with the certification, recordkeeping, and reporting requirements in Sections 26.6 and 26.7 for those sources. 26.2.5 Any facility or source that becomes or is currently subject to the provisions of this regulation by exceeding the applicability threshold in Subsection 26.2.2 will remain subject to this regulation even if the emissions later fall below the applicability threshold. 26.3 Standards By 19 November 1994 the following emissions limitations must be met. Any new source commencing operation after 19 November 1992 must meet the following emission limitations upon commencing operations: 26.3.1 Surface condensers or equivalent controls. (a) If surface condensers are used, the condenser outlet gas temperature shall not exceed the allowable temperature limit described for each associated vapor pressure in the following table; or Allowable condenser outlet gas temperature, EC VOC vapor pressure at 20EC, kPa (psi) -25 >40.01 (5.8) -15 >20.0 (2.9) 0 >10.0 (1.5) 10 >7.0 (1.0) 25 >3.5 (0.5) (b) If other controls such as carbon absorption or incineration are used, the VOC emissions shall be reduced by at least as much as they would be by using a surface condenser. All such controls must be approved by the Division. 26.3.2 Air dryers and production equipment exhaust systems. The owner or operator of a synthesized pharmaceutical manufacturing facility subject to this regulation shall reduce the VOC emissions from all air dryers and production equipment exhaust systems: (a) By at least 90 percent on an hourly basis if actual emissions from all air dryers and production equipment exhaust are 150 kg/day (330 lb/day) or more of VOC or (b) To 15.0 kg/day (33 lb/day) or less if actual emissions from all air dryers and production equipment exhaust are less than 150 kg/day (330 lb/day) of VOC. 26.3.3 Storage Tanks. The owner or operator of a synthesized pharmaceutical manufacturing facility subject to this regulation shall reduce the VOC emissions from storage tanks by: (a) Providing a vapor balance system or equivalent control that is at least 90 percent effective in reducing emissions from truck or railcar deliveries to storage tanks with capacities greater than 7,500 liters (L) (2,000 gallons [gal]) that store VOC with vapor pressures greater than 28.0 kiloPascals (kPa) (4.1 pounds per square inch [psi]) at 20EC (68EF); and (b) Installing pressure/vacuum conservation vents set at a minimum pressure of 0.2 kPa (0.03 pounds per square inch atmospheric [psia]) on all storage tanks that store VOC with vapor pressures greater than 10.0 kPa (1.5 psi) at 20EC (68EF). 26.3.4 Centrifuges, rotary vacuum filters, and other filters. The owner or operator of a synthesized pharmaceutical facility subject to this regulation shall enclose all centrifuges, rotary vacuum filters, and other filters having an exposed liquid surface if the liquid contains VOC and exerts a total VOC vapor pressure of 3.50 kPa (0.5 psi) or more at 20EC (68EF), as determined by ASTM D2879-83. 26.3.5 In-process tanks. The owner or operator of a synthesized pharmaceutical facility subject to this regulation shall install covers on all in-process tanks that contain VOC at any time. These covers shall be constructed of a nonporous or nonabsorbent material and form a tight seal with the sides of the tank and have no gaps or holes. These covers shall remain closed at all times except when production, sampling, maintenance, or inspection procedures require operator access. 26.3.6 Leaks. The owner or operator of a synthesized pharmaceutical manufacturing facility subject to this regulation shall visually inspect for liquid leaks once per week and use a portable VOC detector to inspect for vapor leaks once per month to inspect all equipment listed in Subsections 26.2.1 (a) through (k). All leaks repairs shall be completed as soon as practicable but no later than 15 calendar days after the leak is found. 26.4 Test Methods and Compliance Procedures 26.4.1 If a source uses air pollution control equipment to comply with the requirements of this regulation, compliance shall be demonstrated in accordance with 40 CFR Part 60, Appendix A, Method 18, Method 25, or Method 25A or any other EPA approved method which has been approved by the Director. 26.4.2 Selection of a method for testing compliance shall be based on consideration of total concentration and speciation of the organics present and on consideration of the potential presence of interfering gases. Only Method 25, which measures VOC as carbon, may be used for determining destruction efficiency of incinerators or catalytic incinerators. 26.4.3 Except as indicated in Subsections (a) and (b), a test shall consist of three separate runs, each lasting a minimum of 60 minutes, unless the Director determines that process variables dictate shorter sampling times. (a) When the test is being done to determine the efficiency of a fixed-bed carbon adsorption system with a common exhaust stack for all of the individual adsorber vessels, the test shall consist of three separate runs, each coinciding with one or more complete sequences through the adsorption cycles of all the individual adsorber vessels. (b) When the test is being done to determine the efficiency of a fixed-bed carbon adsorption system with individual exhaust stacks for each adsorber vessel, each adsorber vessel shall be tested individually. The test for each adsorber vessel shall consist of three separate runs. Each run shall coincide with one or more complete adsorption cycles. 26.4.4 Method 1 or 1A of 40 CFR Part 60, Appendix A, shall be used for velocity traverses. 26.4.5 Method 2, 2A, 2C, or 2D of 40 CFR Part 60, Appendix A, shall be used to measure velocity and volumetric flow rates. 26.4.6 Method 3 or 3A of 40 CFR Part 60, Appendix A, shall be used for O2 and CO2 analysis. 26.4.7 Method 4 of 40 CFR Part 60, Appendix A, shall be used to measure stack gas moisture. 26.4.8 Methods 2, 2A, 2C, 2D, 3, 3A and 4 of 40 CFR Part 60, Appendix A, shall be performed, as applicable, at least twice during each test run. 26.4.9 Use of modifications of any of the analytical methods specified in Subsections 26.4.1 through 26.4.8 of this section shall be approved or disapproved by the Director on a case-by-case basis. An owner or operator shall submit sufficient documentation for the Director to find that the analytical methods specified in Subsections 26.4.1 through 26.4.7 will yield inaccurate results and that the proposed modification is appropriate. 26.5 Monitoring for Air Pollution Control Equipment. 26.5.1 At a minimum, continuous monitors measuring the following parameters shall be installed on air pollution control equipment used to control sources subject to this regulation by [the date two years after the effective date of this regulation]: (a) Destruction device combustion temperature; (b) Temperature rise across a catalytic incinerator bed; (c) VOC concentration at the outlet of a carbon adsorption unit at breakthrough; (d) Outlet gas temperature of a refrigerated condenser; and (e) Outlet gas temperature of a non-refrigerated condenser coolant supply system. 26.5.2 Each monitor shall be: (a) Equipped with a recording device, (b) Calibrated quarterly, and (c) Operated at all times that the associated control equipment is operating. 26.6 Recordkeeping 26.6.1 The owner or operator of a pharmaceutical manufacturing facility subject to this regulation shall maintain the following records beginning [the date two years after the effective date of this regulation]: (a) Recording of parameters listed in Subsection 26.5. (b) A record of the solvent true vapor pressure as determined by ASTM D2879- 86, for each VOC used in a source which is subject to this regulation. For a pure solvent, a record of published data reporting the true vapor pressure of that solvent as determined using ASTM D2879-86 is acceptable to fulfill this requirement. 26.6.2 For any leak subject to Subsection 26.3.6(a), which cannot be readily repaired within 24 hours after detection, the following shall be recorded: (a) The name of the leaking equipment; (b) The date and time the leak is detected; (c) The action taken to repair the leak; and (d) The date and time the leak is repaired. 26.6.3 All records required in this Subsection shall be maintained at the facility for a minimum of five years. 26.7 Reporting 26.7.1 Initial Compliance Certification Plan 26.7.1.1 The owner or operator of any facility containing sources subject to this regulation shall submit to the Director an initial compliance certification plan by [the date one year after the effective date of this regulation]. The owner or operator of any facility that becomes subject to this regulation after [the date one year after the effective date of this regulation] shall submit an initial compliance certification for that source immediately upon start-up of the operation. 26.7.1.2 The initial compliance certification shall include as a minimum the following information: (a) The name and location of the facility; (b) The name, address and telephone number of the person responsible for the facility; (c) An identification of subject sources at the facility; (d) The information specified in Subsection 26.7.1.3 for each subject source; and (e) The time at which the facility's "day" begins if a time other than midnight local time is used to define a "day". 26.7.1.3 The initial compliance certification shall also include, as a minimum, the following information for each subject source: (a) Identification of the applicable emission limitation, equipment specification, or work practice, as specified in Section 26.3; (b) The method by which compliance has been or will be achieved; (c) For each source subject to numerical emission limitations, the estimated actual and potential emissions without control, and the basis for the estimate; 26.7.2 Final Compliance Certification 26.7.2.1 By 19 November 1994 or immediately upon startup for a facility which becomes subject to this regulation after 19 November 1994, the owner or operator of any facility containing sources subject to this regulation shall certify to the Director that the facility is in compliance with the provisions of this regulation. 26.7.2.2 The final compliance certification shall include, at a minimum, the following information: (a) The method by which compliance has been achieved for each subject source; (b) For each source subject to numerical emission limitations, the estimated actual and potential emissions without control, and the basis for the estimate; (c) Identification of the control system(s) in use for each subject source; (d) The design performance efficiency of the control system; (e) For each source subject to numerical emission limitations, the estimated emissions after control; (f) Certification that each subject source at the facility is in compliance with the applicable emission limitation, equipment specification, or work practice; (g) An identification of any changes from the initial compliance certification plan. 26.7.3 Reports of Noncompliance with Standards (a) The owner or operator of any facility containing sources subject to this section shall, for each incidence of noncompliance with the standards in Section 26.3, within 30 calendar days of becoming aware of such occurrence, supply the Director with the following information: (i) The name and location of the facility; (ii) The subject source(s) that caused the noncompliance with the standard; (iii) The time and date of first observation of the incident of noncompliance; (iv) The cause and expected duration of the incident of noncompliance; (v) For sources subject to numerical emission limitations, the estimated rate of emissions (expressed in the units of the applicable emission limitation) during the incident and the operating data and calculations used in estimating the emission rate. (vi) The proposed corrective actions and schedule to correct the conditions causing the incidence of noncompliance.